533 results on '"Durantel, David"'
Search Results
2. Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR
3. Meeting report: 36th International Conference on Antiviral Research in Lyon, France – March 13–17, 2023
4. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms
5. Therapies against chronic hepatitis B infections: The times they are a-changin’, but the changing is slow!
6. Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
7. A stable hepatitis D virus-producing cell line for host target and drug discovery
8. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus
9. Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
10. Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro
11. SAT-389 HBV and HBsAg strongly reshape the phenotype, function and metabolism of DCs according to patients’ clinical stage
12. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
13. COVID-19: Discovery, diagnostics and drug development
14. The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA.
15. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
16. Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes
17. Deciphering hepatitis B virus phospho-signature in primary human hepatocytes
18. Publisher Correction: A first experience of transduction for differentiated HepaRG cells using lentiviral technology
19. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection
20. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis
21. Meeting report: 31st International Conference on Antiviral Research
22. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
23. Who Defends the Stem Cell’s Citadel?
24. Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis.
25. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals
26. New treatments to reach functional cure: Virological approaches
27. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
28. Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
29. Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
30. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
31. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus
32. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
33. A first experience of transduction for differentiated HepaRG cells using lentiviral technology
34. Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity
35. Early inhibition of hepatocyte innate responses by hepatitis B virus
36. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells
37. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options
38. Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
39. EGF receptor modulates HEV entry in human hepatocytes
40. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
41. Design, Synthesis and Evaluation of Novel 4‐(4‐Chlorobenzyl)‐6‐methylpyridazin‐3(2 H )‐one Derivatives as Hepatitis B Virus Inhibitors
42. Molecular elucidation of drug-induced abnormal assemblies of the Hepatitis B Virus capsid protein by solid-state NMR
43. Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication
44. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector
45. Combined effect of Vonafexor and Interferon-alpha on HBV replication in primary human hepatocytes
46. Dual antiviral activity of farnesyl transferase inhibitor on hepatitis D virus infection revealed by RT-ddPCR
47. DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection
48. Meeting report: 34th international conference on antiviral research
49. Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
50. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.